Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

NIOSHTIC-2 Publications Search

Search Results

Increased focal adhesion kinase- and urokinase-type plasminogen activator receptor-associated cell signaling in endothelial cells exposed to asbestos.

Authors
Barchowsky-A; Lannon-BM; Elmore-LC; Treadwell-MD
Source
Environ Health Perspect 1997 Sep; 105(Suppl 5):1131-1137
NIOSHTIC No.
00239915
Abstract
Porcine endothelial cells isolated from fresh aortas and third passage human pulmonary microvascular endothelial cells were incubated with chrysotile (12001295) or crocidolite (12001284) asbestos or RCF-1 ceramic fibers. A 1 to 3 hour exposure to 5mg/cm2 of chrysotile caused marked cell elongation and motility. When cells were pretreated with either mannosamine to prevent assembly of glycophosphatidylinositol (GPI) anchored receptors or with herbimycin-A to inhibit tyrosine-kinase activity, little morphological change was noted when chrysotile was added. Affinity purification of GPI anchored urokinase type plasminogen activator receptor from chrysotile exposed cells indicated that asbestos altered the profile of proteins and phosphoprotein complexes with this receptor. Asbestos exposure also increased tyrosine-kinase activities in the complexes. Both chrysotile and crocidolite asbestos increased kinase activities associated with p60 Src or p120 focal adhesion kinase (FAK) factor as indicated by immunoprecipitations with selective monoclonal antibodies. Chrysotile also changed the profile of proteins and phosphoproteins associated with FAK in intact cells. The authors suggest that asbestos initiates endothelial cell phenotypic change through interactions with urokinase type plasminogen activator receptor containing complexes and that this change is mediated through tyrosine kinase cascades.
Keywords
NIOSH-Publication; NIOSH-Grant; Pulmonary-system-disorders; Asbestos-fibers; Carcinogens; Enzyme-activity; Lung-cells; Mammalian-cells; In-vitro-studies
Contact
Pharmacology and Toxicology Dartmouth Medical School Remsen 7650 Hanover, NH 03755-3835
CODEN
EVHPAZ
CAS No.
12001-29-5; 12001-28-4; 1332-21-4
Publication Date
19970901
Document Type
Journal Article
Funding Amount
76183
Funding Type
Grant
Fiscal Year
1997
NTIS Accession No.
NTIS Price
Identifying No.
Grant-Number-R03-OH-03267
ISSN
0091-6765
Priority Area
Asthma and Chronic Obstructive Pulmonary Disease; Disease and Injury; Pulmonary-system-disorders
Source Name
Environmental Health Perspectives
State
NH
Performing Organization
Dartmouth College, Hanover, New Hampshire
TOP